US0028241000 - ABT - 850103 (XNYS)
ABBOTT LABORATORIES INC Share
114,23 USD
Value change
Data point: | () |
Portfolio value (at data point, {date}) | |
Portfolio value (at the start of the period, n/a) | - |
Value change | |
Value change % |
Loading chart data…
ABBOTT LABORATORIES INC
New Comparison Value
Current Prices from ABBOTT LABORATORIES INC
Exchange | Ticker | Currency | Last Trade | Price | Daily Change | Daily Change % |
---|---|---|---|---|---|---|
NYSE |
ABT
|
USD
|
20.12.2024 22:34
|
114,23 USD
| 112,44 USD | 1,59 % |
XETRA |
ABL.DE
|
EUR
|
20.12.2024 17:35
|
109,66 EUR
| 108,10 EUR | 1,44 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | 0,75 % | -2,58 % | 0,47 % | 8,05 % | 4,79 % | 31,81 % |
Firmenprofil zu ABBOTT LABORATORIES INC Aktie
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Investierte Fonds
Folgende Fonds haben in investiert: ABBOTT LABORATORIES INC investiert:
Fonds | Vol. in Mio 7.104,69 | Anteil (%) 12,72 % |
Fonds | Vol. in Mio 5.890,40 | Anteil (%) 3,52 % |
Fonds | Vol. in Mio 10.634,24 | Anteil (%) 2,92 % |
Fonds | Vol. in Mio 6.334,12 | Anteil (%) 1,93 % |
Fonds | Vol. in Mio 14.783,31 | Anteil (%) 1,23 % |
Unternehmensdaten zur ABBOTT LABORATORIES INC Aktie
Name ABBOTT LABORATORIES INC
Firma Abbott Laboratories
Symbol ABT
Website https://www.abbott.com
Heimatbörse
NYSE
WKN 850103
ISIN US0028241000
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Devices
CEO Mr. Robert B. Ford
Marktkapitalisierung 203 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 114,0 T
Adresse 100 Abbott Park Road, 60064-6400 North Chicago
IPO Datum 1980-03-17
Dividenden von 'ABBOTT LABORATORIES INC'
Ex-Datum | Dividende pro Aktie |
---|---|
15.10.2024 | 0,55 USD |
15.07.2024 | 0,55 USD |
12.04.2024 | 0,55 USD |
11.01.2024 | 0,55 USD |
12.10.2023 | 0,51 USD |
13.07.2023 | 0,51 USD |
13.04.2023 | 0,51 USD |
12.01.2023 | 0,51 USD |
13.10.2022 | 0,47 USD |
14.07.2022 | 0,47 USD |
Aktien-Splits
Datum | Split |
---|---|
02.01.2013 | 10000:4798 |
03.05.2004 | 10000:9356 |
01.06.1998 | 2:1 |
01.06.1992 | 2:1 |
01.06.1990 | 2:1 |
02.06.1986 | 2:1 |
01.06.1981 | 2:1 |
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | ABL.F |
NYSE | ABT |
XETRA | ABL.DE |
Weitere Aktien
Investoren die ABBOTT LABORATORIES INC die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.